Silence Therapeutics (SLN) Cash & Equivalents Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | -91.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.28% |
| Dec 31, 2025 | -90.71% |
| Sep 30, 2025 | 1.91% |
| Jun 30, 2025 | -69.80% |
| Mar 31, 2025 | -54.76% |
| Dec 31, 2024 | 80.93% |
| Sep 30, 2024 | 8.05% |
| Jun 30, 2024 | 271.57% |
| Mar 31, 2024 | 152.48% |
| Dec 31, 2023 | 36.17% |
| Sep 30, 2023 | -29.78% |
| Jun 30, 2023 | -42.73% |
| Mar 31, 2023 | -28.61% |
| Dec 31, 2022 | -50.32% |
| Sep 30, 2022 | 7.68% |
| Jun 30, 2022 | -34.78% |
| Mar 31, 2022 | 26.19% |
| Dec 31, 2021 | 173.50% |
| Sep 30, 2021 | 448.67% |
| Jun 30, 2021 | 676.88% |
| Dec 31, 2020 | 108.59% |
| Jun 30, 2020 | -13.44% |
| Dec 31, 2019 | -37.17% |